Related Experiment Video
Updated: Aug 24, 2025

Chuzhen Therapy as a Non-Invasive Traditional Chinese Therapy for Neck Pain
Published on: June 6, 2025
Some conservative interventions are more effective than others for people with chronic non-specific neck pain: a
Greta Castellini1, Paolo Pillastrini2, Carla Vanti1
1IRCCS Istituto Ortopedico Galeazzi, Unit of Clinical Epidemiology, Milan, Italy.
Question:
Which is the most effective conservative intervention for patients with non-specific chronic neck pain (CNSNP)?
Design:
A systematic review and network meta-analysis of randomised clinical trials.
Participants:
Adults with CNSNP of at least 3 months duration.
Interventions:
All available pharmacological and non-pharmacological interventions.
Outcome Measures:
The primary outcomes were pain intensity and disability. The secondary outcome was adverse events.
Results:
Overall, 119 RCTs (12,496 patients; 32 interventions) were included. Risk of bias was low in 50.4% of trials, unclear in 22.7% and high in 26.9%. Compared with inert treatment, a combination of active and/or passive multimodal non-pharmacological inventions (eg, exercise and manual therapy) were effective for pain on a 0-to-10 scale at 1 month (MD range 0.84 to 3.74) and at 3 to 6 months (MD range 1.06 to 1.49), and effective on disability on a 0-to-100 scale at 1 month (MD range 10.26 to 14.09) and 3 to 6 months (MD range 5.60 to 16.46). These effects ranged from possible to definite clinical relevance. Compared with inert treatment, anti-inflammatory drugs alone or in combination with another non-pharmacological treatment did not reduce pain at 1 month or 3 to 6 months. At 12 months, no superiority was found over inert treatment on both outcomes. Most mild adverse events were experienced following acupuncture/dry needling intervention. On average, the evidence varied from low to very low certainty.
Conclusions:
While multimodal non-pharmacological interventions may reduce pain and disability for up to 3 to 6 months of follow-up when compared with inert treatment, the evidence was very uncertain about their effects. Better quality and larger trials are needed to improve the certainty of evidence.
Registration:
PROSPERO CRD42019124501.

